Our Business Units Intertwining strength, leadership and technical capabilities, Johnson Matthey's global network of business units become one to resolve your API development and manufacturing challenges. Collectively, we provide seamless, worry free control throughout the duration of your project.
Pharmaceutical Services: API Chemical Services Provider www.jmpharmaservices.com
Johnson Matthey Pharma Services provides API outsourcing solutions throughout the small molecule drug development process. With over 35 years’ experience and more than 125 professionals in the Boston area, our vast range of services encompasses all areas of research, development, and cGMP manufacturing. Strong regulatory compliance underscores our services for custom synthesis, PR&D, scale-up, optimization, and validation of NCE’s. Beyond traditional chemistry services, we provide solutions for complex molecules via separation technologies, asymmetric/chiral development and analytical technologies, catalytic process screening, and solid form screening. Our services are retained for a variety of compounds including small molecules, natural products (extraction), controlled drug substances, and highly potent active ingredients. Our Devens, MA facility houses self-contained manufacturing suites featuring 50-500 gallon glass-lined and hastelloy reactors with cryogenic cooling capabilities, more than 35 kilo-laboratories, including a dedicated high-potency lab, and a catalytic screening laboratory. Johnson Matthey Research and Development, located in Yantai, China, specializes in process R&D and non-cGMP manufacture of raw materials and advanced intermediates from gram to multi-hundred kg scale. Top
Pharmaceutical Materials: USA Manufacturer of Bulk API www.jmpharma.com
Johnson Matthey Pharmaceutical Materials, based in West Deptford, NJ is a leading manufacturer of active pharmaceutical ingredients. We provide the strength and know-how behind your generic and branded products in the US. Our strictly controlled, self contained reactor trains (up to 2,000 gallons; 7,500 liters) and DEA registered facilities produce Phase II, Phase III as well as commercial bulk APIs specializing in Class I-V controlled substances and oncology products under cGMP conditions. Behind the scenes, our scientific team works to improve and refine your process with expertise in process development, optimization, validation and scale-up, reducing time and cost. Our extensive product list includes cisplatin, carboplatin, fentanyl citrate and base, hydrocodone bitartrate, hydromorphone HCI, oxycodone HCI and oxymorphone HCl. Strict quality control and regulatory compliance are the foundation of every project we undertake. We maintain precision testing and analysis throughout every step of your project and no product will be released until it has been fully tested, reviewed and documented. Top
Macfarlan Smith: European Manufacturer of Controlled Substances www.macsmith.com
Macfarlan Smith Limited, is a world leader in the production of alkaloid opiates and other controlled drugs. As one of the world's oldest pharmaceutical companies, Macfarlan Smith has manufactured and developed active pharmaceutical ingredients and intermediates for almost 200 years, and today the company operates a state-of-the-art plant to the highest level of cGMP. Today, we are the world's leading manufacturer of opiate alkaloids and together with Johnson Matthey Pharmaceutical Materials (NJ, USA) and Johnson Matthey Pharma Services (MA, USA), we are able to provide the full spectrum of development, from drug discovery through to bulk production. Macfarlan Smith offers a comprehensive contract manufacturing facility ranging from the development of novel synthetic processes, through labscale production to the provision of multi-tonne custom synthesis, which includes the toll extraction of active principles from natural products. Top
Catalysis & Chiral Technologies: Your Catalyst Provider www.jmcct.com
Catalysis and Chiral Technologies is the only global catalytic technology partner that can provide trusted expertise for heterogeneous, homogeneous, chiral and biocatalytic technologies for customers in the pharmaceutical, fine chemical and agrochemical industries. We deliver high quality products and excellent service to help our customers reduce their development and manufacturing costs.. Dedicated to serving the pharmaceutical and fine chemical sectors, the Catalysis & Chiral Technologies (CCT) business unit within Johnson Matthey operates R&D labs and commercial scale manufacturing around the world that are focused on developing new catalyst technologies designed to help you succeed. Whether you are looking for an existing catalyst, customized solution, or hope to improve an existing process, our highly accessible support team is ready to work with you. Top
|